It looks like you're using an unsecure version of Internet Explorer. Using an outdated browser makes your computer unsafe. For the best and safest website experience, please update your
or please use
or
Obesity | GPnotebook TV
This site is intended for UK healthcare professionals
Dr Anish Kotecha summarises a study into the use of the glucagon-like peptide-1 receptor agonist semaglutide, alongside a lifestyle intervention, to reduce weight.
Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.
Did you know? You can now track the videos you watch to claim CPD credits
To get started, register for a GPnotebook Pro account, and then use your credentials to log in to GPnotebook TV